Catalyst Wire Dossier Catalyst Wire Dossier

Pneumococcal Vaccine 2189242A

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pneumococcal Vaccine 2189242A, covering 2016-09-28 to 2017-10-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination [Phase 2]

See pricing